Ciclesonide’s Role in Modern Respiratory Care Ciclesonide is a unique, inhaled corticosteroid (ICS) recognized for its efficacy in managing inflammatory conditions, primarily asthma and allergic rhinitis. What sets Ciclesonide apart is its “prodrug” nature; it is administered as an inactive compound and is only activated once it reaches the lungs. This targeted activation minimizes systemic side effects, enhancing its safety profile and patient compliance compared to some other corticosteroids. As a cornerstone in the long-term management of chronic respiratory diseases, Ciclesonide continues to be in high demand across global healthcare markets. For manufacturers and distributors of Ciclesonide, whether as an Active Pharmaceutical Ingredient (API) or in various finished dosage forms…